Skip to main content

Biomarkers of the Antioxidant Response: A Focus on Liver Carcinogenesis

  • Reference work entry
  • First Online:
Biomarkers in Liver Disease

Abstract

Many studies have demonstrated the association of oxidative stress caused by excessive and sustained production of reactive species with chronic inflammatory conditions, neurodegenerative diseases, diabetes mellitus, atherosclerosis, and cancer. The main mechanism of redox control relies on the cellular antioxidant response. Nevertheless, oxidative stress and oxidative damage to biomolecules are events inherent to the process of carcinogenesis. Antioxidant response systems do not operate in isolation, as there is significant convergence among thermodynamically favored systems. Three main systems may be identified: glutathione, thioredoxins (TRX), and nicotinamide adenine dinucleotide phosphate (NADPH). Liver tumors frequently exhibit overexpression of one or more proteins belonging to the antioxidant system, for example, glutathione reductase (GSR), glutathione S-transferase P (GSTP), gamma-glutamyl transferase (GGT), glucose-6-phosphate dehydrogenase (G6PD), thioredoxin reductase (TXNR), NAD(P)H dehydrogenase [quinone] 1 (NQO1), and prostaglandin reductase 1 (PTGR1). The increased expression of these enzymes is suggested as biomarker that favors tumor development by stimulating proliferation, angiogenesis, and metastasis or by preventing cell death. The loss of expression of some antioxidant enzymes could be used as biomarkers too such as catalase (CAT) and superoxide dismutase (SOD). Therefore, the expression of these proteins shows predictive value for the prognosis and risk of liver cancer recurrence in patients. In this chapter, we discuss the most recent findings regarding the enzymatic antioxidant cellular response that occurs during liver carcinogenesis and how these systems could be used as biomarkers in the clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 449.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

4-HNE:

4-Hydroxynonenal

8-OH-dG:

8-hydroxy-20-deoxyguanosine

AKR:

Aldo-keto reductase

ATF-2:

Activating transcription factor

ATM:

Ataxia telangiectasia mutated

CAT:

Catalase

CBR1:

Carbonyl reductase 1

G6PD:

Glucose-6-phosphate dehydrogenase

GCL:

Glutamate cysteine ligase

GGT:

Gamma-glutamyl transferase

GPX:

Glutathione peroxidase

GS:

Glutathione synthetase

GSH and GSSG:

Reduced and oxidized glutathione

GSR:

Glutathione reductase

GST:

Glutathione S-transferases

HCC:

Hepatocellular carcinoma

HIF:

Hypoxia-inducible factors

HMOX:

Heme oxygenase

HNF4α:

Hepatocyte nuclear factor alpha

MDA:

Malondialdehyde

MDR:

Multidrug resistance protein

MT:

Metallothionein

NADPH:

Nicotinamide adenine dinucleotide phosphate

NFE2L2:

Nuclear factor (erythroid-derived 2)-like 2

NF-kB:

Nuclear factor kB

NQO1:

NADPH quinone oxidoreductase 1

PI3K:

Phosphoinositide 3 kinase

PLC:

Phospholipase C

PPAR:

Peroxisome proliferator-activated receptors

PRX:

Peroxiredoxin

PTEN:

Phosphatase and tensin homolog

PTGR:

Prostaglandin reductase

RAR:

Retinoic acid receptors

RNS:

Reactive nitrogen species

ROS:

Reactive oxygen species

SOD:

Superoxide dismutase

TRX:

Thioredoxin

TXNR:

Thioredoxin reductase

References

  • Albrethsen J, Miller LM, Novikoff PM, Angeletti RH. Gel-based proteomics of liver cancer progression in rat. Biochim Biophys Acta. 2011;1814(10):1367–76.

    Article  CAS  PubMed  Google Scholar 

  • Arriaga JM, Levy EM, Bravo AI, Bayo SM, Amat M, Aris M, Hannois A, Bruno L, Roberti MP, Loria FS, Pairola A, Huertas E, Mordoh J, Bianchini M. Metallothionein expression in colorectal cancer: relevance of different isoforms for tumor progression and patient survival. Hum Pathol. 2012;43(2):197–208.

    Article  CAS  PubMed  Google Scholar 

  • Backos DS, Fritz KS, McArthur DG, Kepa JK, Donson AM, Petersen DR, Foreman NK, Franklin CC, Reigan P. Glycation of glutamate cysteine ligase by 2-deoxy-d-ribose and its potential impact on chemoresistance in glioblastoma. Neurochem Res. 2013;38(9):1838–49.

    Article  CAS  PubMed  Google Scholar 

  • Bae YS, Oh H, Rhee SG, Yoo YD. Regulation of reactive oxygen species generation in cell signaling. Mol Cells. 2011;32(6):491–509.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bartsch H, Nair J, Owen RW. Exocyclic DNA adducts as oxidative stress markers in colon carcinogenesis: potential role of lipid peroxidation, dietary fat and antioxidants. Biol Chem. 2002;383(6):915–21.

    Article  CAS  PubMed  Google Scholar 

  • Bobko AA, Eubank TD, Voorhees JL, Efimova OV, Kirilyuk IA, Petryakov S, Trofimiov DG, Marsh CB, Zweier JL, Grigor'ev IA, Samouilov A, Khramtsov VV. In vivo monitoring of pH, redox status, and glutathione using L-band EPR for assessment of therapeutic effectiveness in solid tumors. Magn Reson Med. 2012;67(6):1827–36.

    Article  CAS  PubMed  Google Scholar 

  • Buranrat B, Chau-in S, Prawan A, Puapairoj A, Zeekpudsa P, Kukongviriyapan V. NQO1 expression correlates with cholangiocarcinoma prognosis. Asian Pac J Cancer Prev. 2012;13(Suppl):131–6.

    PubMed  Google Scholar 

  • Chellappa K, Jankova L, Schnabl JM, Pan S, Brelivet Y, Fung CL, Chan C, Dent OF, Clarke SJ, Robertson GR, Sladek FM. Src tyrosine kinase phosphorylation of nuclear receptor HNF4alpha correlates with isoform-specific loss of HNF4alpha in human colon cancer. Proc Natl Acad Sci U S A. 2012;109(7):2302–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen ZS, Tiwari AK. Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases. FEBS J. 2011;278(18):3226–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cheng ML, Lu YF, Chen H, Shen ZY, Liu J. Liver expression of Nrf2-related genes in different liver diseases. Hepatobiliary Pancreat Dis Int. 2015;14(5):485–91.

    Article  PubMed  Google Scholar 

  • Circu ML, Aw TY. Glutathione and apoptosis. Free Radic Res. 2008;42(8):689–706.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Colak D, Chishti MA, Al-Bakheet AB, Al-Qahtani A, Shoukri MM, Goyns MH, Ozand PT, Quackenbush J, Park BH, Kaya N. Integrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old. Mol Cancer. 2010;9:146.

    Article  PubMed  PubMed Central  Google Scholar 

  • Corti A, Franzini M, Paolicchi A, Pompella A. Gamma-glutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting. Anticancer Res. 2010;30(4):1169–81.

    CAS  PubMed  Google Scholar 

  • Czeczot H, Scibior D, Skrzycki M, Podsiad M. Glutathione and GSH-dependent enzymes in patients with liver cirrhosis and hepatocellular carcinoma. Acta Biochim Pol. 2006;53(1):237–42.

    CAS  PubMed  Google Scholar 

  • Dalleau S, Baradat M, Gueraud F, Huc L. Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance. Cell Death Differ. 2013;20(12):1615–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dick RA, Kwak MK, Sutter TR, Kensler TW. Antioxidative function and substrate specificity of NAD(P)H-dependent alkenal/one oxidoreductase. A new role for leukotriene B4 12-hydroxydehydrogenase/15-oxoprostaglandin 13-reductase. J Biol Chem. 2001;276(44):40803–10.

    Article  CAS  PubMed  Google Scholar 

  • Droge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82(1):47–95.

    Article  CAS  PubMed  Google Scholar 

  • El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132(7):2557–76.

    Article  CAS  PubMed  Google Scholar 

  • Endo S, Matsunaga T, Soda M, Tajima K, Zhao HT, El-Kabbani O, Hara A. Selective inhibition of the tumor marker AKR1B10 by antiinflammatory N-phenylanthranilic acids and glycyrrhetic acid. Biol Pharm Bull. 2010;33(5):886–90.

    Article  CAS  PubMed  Google Scholar 

  • Franco R, Cidlowski JA. Glutathione efflux and cell death. Antioxid Redox Signal. 2012;17(12):1694–713.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Franzini M, Corti A, Martinelli B, Del Corso A, Emdin M, Parenti GF, Glauber M, Pompella A, Paolicchi A. Gamma-glutamyltransferase activity in human atherosclerotic plaques – biochemical similarities with the circulating enzyme. Atherosclerosis. 2009;202(1):119–27.

    Article  CAS  PubMed  Google Scholar 

  • Fu TY, Hou YY, Chu ST, Liu CF, Huang CH, Chen HC, Hsiao M, Lu PJ, Wang JS, Ger LP. Manganese superoxide dismutase and glutathione peroxidase as prognostic markers in patients with buccal mucosal squamous cell carcinomas. Head Neck. 2011;33(11):1606–15.

    Article  PubMed  Google Scholar 

  • Furuta E, Okuda H, Kobayashi A, Watabe K. Metabolic genes in cancer: their roles in tumor progression and clinical implications. Biochim Biophys Acta. 2010;1805(2):141–52.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Gan L, Johnson JA. Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases. Biochim Biophys Acta. 2014;1842(8):1208–18.

    Article  CAS  PubMed  Google Scholar 

  • Gumulec J, Raudenska M, Adam V, Kizek R, Masarik M. Metallothionein – immunohistochemical cancer biomarker: a meta-analysis. PLoS One. 2014;9(1):e85346.

    Article  PubMed  PubMed Central  Google Scholar 

  • Halliwell B, Gutteridge JM. Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet. 1984;1(8391):1396–7.

    Article  CAS  PubMed  Google Scholar 

  • Hanigan MH, Frierson Jr HF, Brown JE, Lovell MA, Taylor PT. Human ovarian tumors express gamma-glutamyl transpeptidase. Cancer Res. 1994;54(1):286–90.

    CAS  PubMed  Google Scholar 

  • Heringlake S, Hofdmann M, Fiebeler A, Manns MP, Schmiegel W, Tannapfel A. Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours. J Hepatol. 2010;52(2):220–7.

    Article  CAS  PubMed  Google Scholar 

  • Ho DW, Yang ZF, Yi K, Lam CT, Ng MN, Yu WC, Lau J, Wan T, Wang X, Yan Z, Liu H, Zhang Y, Fan ST. Gene expression profiling of liver cancer stem cells by RNA-sequencing. PLoS One. 2012;7(5):e37159.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jamshidi M, Bartkova J, Greco D, Tommiska J, Fagerholm R, Aittomaki K, Mattson J, Villman K, Vrtel R, Lukas J, Heikkila P, Blomqvist C, Bartek J, Nevanlinna H. NQO1 expression correlates inversely with NFkappaB activation in human breast cancer. Breast Cancer Res Treat. 2012;132(3):955–68.

    Article  CAS  PubMed  Google Scholar 

  • Kekec Y, Paydas S, Tuli A, Zorludemir S, Sakman G, Seydaoglu G. Antioxidant enzyme levels in cases with gastrointesinal cancer. Eur J Intern Med. 2009;20(4):403–6.

    Article  CAS  PubMed  Google Scholar 

  • Kim S, Jung WH, Koo JS. Differences in autophagy-related activity by molecular subtype in triple-negative breast cancer. Tumour Biol. 2012;33(5):1681–94.

    Article  CAS  PubMed  Google Scholar 

  • Lin L, Qin Y, Jin T, Liu S, Zhang S, Shen X, Lin Z. Significance of NQO1 overexpression for prognostic evaluation of gastric adenocarcinoma. Exp Mol Pathol. 2014;96(2):200–5.

    Article  CAS  PubMed  Google Scholar 

  • Liu ZM, Hasselt CA, Song FZ, Vlantis AC, Cherian MG, Koropatnick J, Chen GG. Expression of functional metallothionein isoforms in papillary thyroid cancer. Mol Cell Endocrinol. 2009;302(1):92–8.

    Article  CAS  PubMed  Google Scholar 

  • Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362(9399):1907–17.

    Article  PubMed  Google Scholar 

  • Marra M, Sordelli IM, Lombardi A, Lamberti M, Tarantino L, Giudice A, Stiuso P, Abbruzzese A, Sperlongano R, Accardo M, Agresti M, Caraglia M, Sperlongano P. Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview. J Transl Med. 2011;9:171.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Matos JM, Witzmann FA, Cummings OW, Schmidt CM. A pilot study of proteomic profiles of human hepatocellular carcinoma in the United States. J Surg Res. 2009;155(2):237–43.

    Article  CAS  PubMed  Google Scholar 

  • Mougiakakos D, Okita R, Ando T, Durr C, Gadiot J, Ichikawa J, Zeiser R, Blank C, Johansson CC, Kiessling R. High expression of GCLC is associated with malignant melanoma of low oxidative phenotype and predicts a better prognosis. J Mol Med (Berl). 2012;90(8):935–44.

    Article  CAS  Google Scholar 

  • Murakami A, Yakabe K, Yoshidomi K, Sueoka K, Nawata S, Yokoyama Y, Tsuchida S, Al-Mulla F, Sugino N. Decreased carbonyl reductase 1 expression promotes malignant behaviours by induction of epithelial mesenchymal transition and its clinical significance. Cancer Lett. 2012;323(1):69–76.

    Article  CAS  PubMed  Google Scholar 

  • Murtas D, Piras F, Minerba L, Ugalde J, Floris C, Maxia C, Demurtas P, Perra MT, Sirigu P. Nuclear 8-hydroxy-2′-deoxyguanosine as survival biomarker in patients with cutaneous melanoma. Oncol Rep. 2010;23(2):329–35.

    PubMed  Google Scholar 

  • Noh SJ, Bae JS, Jamiyandorj U, Park HS, Kwon KS, Jung SH, Youn HJ, Lee H, Park BH, Chung MJ, Moon WS, Kang MJ, Jang KY. Expression of nerve growth factor and heme oxygenase-1 predict poor survival of breast carcinoma patients. BMC Cancer. 2013;13:516.

    Article  PubMed  PubMed Central  Google Scholar 

  • Noike T, Miwa S, Soeda J, Kobayashi A, Miyagawa S. Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer. Hum Pathol. 2008;39(2):201–8.

    Article  CAS  PubMed  Google Scholar 

  • Ooi A, Wong JC, Petillo D, Roossien D, Perrier-Trudova V, Whitten D, Min BW, Tan MH, Zhang Z, Yang XJ, Zhou M, Gardie B, Molinie V, Richard S, Tan PH, Teh BT, Furge KA. An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell. 2011;20(4):511–23.

    Article  CAS  PubMed  Google Scholar 

  • Oyagbemi AA, Azeez OI, Saba AB. Interactions between reactive oxygen species and cancer: the roles of natural dietary antioxidants and their molecular mechanisms of action. Asian Pac J Cancer Prev. 2009;10(4):535–44.

    PubMed  Google Scholar 

  • Pallardo FV, Markovic J, Garcia JL, Vina J. Role of nuclear glutathione as a key regulator of cell proliferation. Mol Aspects Med. 2009;30(1–2):77–85.

    Article  CAS  PubMed  Google Scholar 

  • Paolicchi A, Emdin M, Ghliozeni E, Ciancia E, Passino C, Popoff G, Pompella A. Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation. 2004;109(11):1440.

    Article  PubMed  Google Scholar 

  • Pastor MD, Nogal A, Molina-Pinelo S, Melendez R, Salinas A, Gonzalez De la Pena M, Martin-Juan J, Corral J, Garcia-Carbonero R, Carnero A, Paz-Ares L. Identification of proteomic signatures associated with lung cancer and COPD. J Proteomics. 2013;89:227–37.

    Article  CAS  PubMed  Google Scholar 

  • Penney RB, Roy D. Thioredoxin-mediated redox regulation of resistance to endocrine therapy in breast cancer. Biochim Biophys Acta. 2013;1836(1):60–79.

    CAS  PubMed  Google Scholar 

  • Perez-Carreon JI, Lopez-Garcia C, Fattel-Fazenda S, Arce-Popoca E, Aleman-Lazarini L, Hernandez-Garcia S, Le Berre V, Sokol S, Francois JM, Villa-Trevino S. Gene expression profile related to the progression of preneoplastic nodules toward hepatocellular carcinoma in rats. Neoplasia. 2006;8(5):373–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Petrelli A, Perra A, Cora D, Sulas P, Menegon S, Manca C, Migliore C, Kowalik MA, Ledda-Columbano GM, Giordano S, Columbano A. MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC). Hepatology. 2014;59(1):228–41.

    Article  CAS  PubMed  Google Scholar 

  • Reddy NM, Kleeberger SR, Bream JH, Fallon PG, Kensler TW, Yamamoto M, Reddy SP. Genetic disruption of the Nrf2 compromises cell-cycle progression by impairing GSH-induced redox signaling. Oncogene. 2008;27(44):5821–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Reszka E. Selenoproteins in bladder cancer. Clin Chim Acta. 2012;413(9–10):847–54.

    Article  CAS  PubMed  Google Scholar 

  • Rivollier A, Perrin-Cocon L, Luche S, Diemer H, Strub JM, Hanau D, van Dorsselaer A, Lotteau V, Rabourdin-Combe C, Rabilloud T, Servet-Delprat C. High expression of antioxidant proteins in dendritic cells: possible implications in atherosclerosis. Mol Cell Proteomics. 2006;5(4):726–36.

    Article  CAS  PubMed  Google Scholar 

  • Saeidnia S, Abdollahi M. Antioxidants: friends or foe in prevention or treatment of cancer: the debate of the century. Toxicol Appl Pharmacol. 2013;271(1):49–63.

    Article  CAS  PubMed  Google Scholar 

  • Sainz RM, Lombo F, Mayo JC. Radical decisions in cancer: redox control of cell growth and death. Cancers (Basel). 2012;4(2):442–74.

    Article  CAS  Google Scholar 

  • Sanchez-Perez Y, Carrasco-Legleu C, Garcia-Cuellar C, Perez-Carreon J, Hernandez-Garcia S, Salcido-Neyoy M, Aleman-Lazarini L, Villa-Trevino S. Oxidative stress in carcinogenesis. Correlation between lipid peroxidation and induction of preneoplastic lesions in rat hepatocarcinogenesis. Cancer Lett. 2005;217(1):25–32.

    Article  CAS  PubMed  Google Scholar 

  • Sanchez-Rodriguez R, Torres-Mena JE, De-la-Luz-Cruz M, Bernal-Ramos GA, Villa-Trevino S, Chagoya-Hazas V, Landero-Lopez L, Garcia-Roman R, Rouimi P, Del-Pozo-Yauner L, Melendez-Zajgla J, Perez-Carreon JI. Increased expression of prostaglandin reductase 1 in hepatocellular carcinomas from clinical cases and experimental tumors in rats. Int J Biochem Cell Biol. 2014;53:186–94.

    Article  CAS  PubMed  Google Scholar 

  • Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P, Bergo MO. Antioxidants accelerate lung cancer progression in mice. Sci Transl Med. 2014;6(221):221ra215.

    Article  Google Scholar 

  • Sengupta R, Holmgren A. The role of thioredoxin in the regulation of cellular processes by S-nitrosylation. Biochim Biophys Acta. 2012;1820(6):689–700.

    Article  CAS  PubMed  Google Scholar 

  • Shimizu T, Inoue KI, Hachiya H, Shibuya N, Shimoda M, Kubota K. Frequent alteration of the protein synthesis of enzymes for glucose metabolism in hepatocellular carcinomas. J Gastroenterol. 2014;49(9):1324–1332. PMCID: PMC4156784.

    Google Scholar 

  • Sorokina LV, Solyanik GI, Pyatchanina TV. The evaluation of prooxidant and antioxidant state of two variants of lewis lung carcinoma: a comparative study. Exp Oncol. 2010;32(4):249–53.

    CAS  PubMed  Google Scholar 

  • Sun QK, Zhu JY, Wang W, Lv Y, Zhou HC, Yu JH, Xu GL, Ma JL, Zhong W, Jia WD. Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma. Med Oncol. 2014;31(1):786.

    Article  PubMed  Google Scholar 

  • Suzuki S, Pitchakarn P, Ogawa K, Naiki-Ito A, Chewonarin T, Punfa W, Asamoto M, Shirai T, Takahashi S. Expression of glutathione peroxidase 2 is associated with not only early hepatocarcinogenesis but also late stage metastasis. Toxicology. 2013;311(3):115–23.

    Article  CAS  PubMed  Google Scholar 

  • Tak E, Lee S, Lee J, Rashid MA, Kim YW, Park JH, Park WS, Shokat KM, Ha J, Kim SS. Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells. J Hepatol. 2011;54(2):328–39.

    Article  CAS  PubMed  Google Scholar 

  • Uchida M, Sugaya M, Kanamaru T, Hisatomi H. Alternative RNA splicing in expression of the glutathione synthetase gene in human cells. Mol Biol Rep. 2010;37(4):2105–9.

    Article  CAS  PubMed  Google Scholar 

  • Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44–84.

    Article  CAS  PubMed  Google Scholar 

  • Wakai T, Shirai Y, Sakata J, Matsuda Y, Korita PV, Takamura M, Ajioka Y, Hatakeyama K. Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma. Int J Clin Exp Pathol. 2011;4(4):363–70.

    PubMed  PubMed Central  Google Scholar 

  • Wang MY, Liehr JG. Lipid hydroperoxide-induced endogenous DNA adducts in hamsters: possible mechanism of lipid hydroperoxide-mediated carcinogenesis. Arch Biochem Biophys. 1995;316(1):38–46.

    Article  CAS  PubMed  Google Scholar 

  • Wang X, Chorley BN, Pittman GS, Kleeberger SR, Brothers 2nd J, Liu G, Spira A, Bell DA. Genetic variation and antioxidant response gene expression in the bronchial airway epithelium of smokers at risk for lung cancer. PLoS One. 2010;5(8):e11934.

    Article  PubMed  PubMed Central  Google Scholar 

  • Werynska B, Pula B, Muszczynska-Bernhard B, Gomulkiewicz A, Piotrowska A, Prus R, Podhorska-Okolow M, Jankowska R, Dziegiel P. Metallothionein 1F and 2A overexpression predicts poor outcome of non-small cell lung cancer patients. Exp Mol Pathol. 2013;94(1):301–8.

    Article  CAS  PubMed  Google Scholar 

  • Yang Y, Zhang Y, Wu Q, Cui X, Lin Z, Liu S, Chen L. Clinical implications of high NQO1 expression in breast cancers. J Exp Clin Cancer Res. 2014;33:14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yin Y, Liu Q, Wang B, Chen G, Xu L, Zhou H. Expression and function of heme oxygenase-1 in human gastric cancer. Exp Biol Med (Maywood). 2012;237(4):362–71.

    Article  CAS  Google Scholar 

  • Yoon BI, Kim YH, Yi JY, Kang MS, Jang JJ, Joo KH, Kim Y, McHugh Law J, Kim DY. Expression of thioredoxin during progression of hamster and human cholangiocarcinoma. Cancer Sci. 2010;101(1):281–8.

    Article  CAS  PubMed  Google Scholar 

  • Yu Z, Peng S, Hong-Ming P, Kai-Feng W. Expression of multi-drug resistance-related genes MDR3 and MRP as prognostic factors in clinical liver cancer patients. Hepatogastroenterology. 2012;59(117):1556–9.

    PubMed  Google Scholar 

  • Zhang H, Forman HJ. Glutathione synthesis and its role in redox signaling. Semin Cell Dev Biol. 2012;23(7):722–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zuniga-Garcia V, Chavez-Lopez Mde G, Quintanar-Jurado V, Gabino-Lopez NB, Hernandez-Gallegos E, Soriano-Rosas J, Perez-Carreon JI, Camacho J. Differential expression of ion channels and transporters during hepatocellular carcinoma development. Dig Dis Sci. 2015;60(8):2373–83.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Ricardo Sánchez-Rodríguez or Julio Isael Pérez-Carreón .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media Dordrecht

About this entry

Cite this entry

Sánchez-Rodríguez, R., Torres-Mena, J.E., del Pozo Yauner, L., Pérez-Carreón, J.I. (2017). Biomarkers of the Antioxidant Response: A Focus on Liver Carcinogenesis. In: Patel, V., Preedy, V. (eds) Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7675-3_36

Download citation

Publish with us

Policies and ethics